This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Azacitidine improves QOL in myelodysplastic syndrome. Pharmacoecon. Outcomes News 369, 10 (2002). https://doi.org/10.1007/BF03279266
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279266